42779-75-9 Usage
Uses
Used in Chemical Synthesis:
2-Chloro-6-Methylpyridin-4-ol is used as a catalyst in organic synthesis for its ability to facilitate and enhance the efficiency of chemical reactions. Its unique structure allows it to participate in various reaction mechanisms, making it a valuable tool in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Chloro-6-Methylpyridin-4-ol is utilized as a ligand for the extraction and separation of actinide and lanthanide elements from solutions. This application is crucial in the processing and purification of these elements, which are often used in medical and research settings.
Used in Drug Development:
CMPO has also been employed in the development of new drugs, capitalizing on its unique structure and functional groups to create novel therapeutic agents. Its potential applications in drug development include the synthesis of compounds with specific biological activities, contributing to the advancement of medicinal chemistry.
Overall, 2-Chloro-6-Methylpyridin-4-ol's diverse applications across different industries highlight its importance as a versatile and valuable chemical compound. Its unique structure and functional groups make it a promising candidate for further research and development in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 42779-75-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,7,7 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 42779-75:
(7*4)+(6*2)+(5*7)+(4*7)+(3*9)+(2*7)+(1*5)=149
149 % 10 = 9
So 42779-75-9 is a valid CAS Registry Number.
42779-75-9Relevant academic research and scientific papers
Synthetic Route Design of AZD4635, an A2AR Antagonist
Littleson, Mairi M.,Campbell, Andrew D.,Clarke, Adam,Dow, Mark,Ensor, Gareth,Evans, Matthew C.,Herring, Adam,Jackson, Bethany A.,Jackson, Lucinda V.,Karlsson, Staffan,Klauber, David J.,Legg, Danny H.,Leslie, Kevin W.,Morav?ík, ?tefan,Parsons, Chris D.,Ronson, Thomas O.,Meadows, Rebecca E.
supporting information, p. 1407 - 1419 (2019/08/12)
The AstraZeneca approach to synthetic Route Design is exemplified through our AZD4635 chemical development program. The identification of possible new route concepts is presented, as well as their subsequent prioritization for practical exploration based on project objectives. Selected ideas were tested to demonstrate proof of concept for the bond formation strategy and, where successful, were fed into a decision tool based on key SELECTion principles.
